Recombinant granulocyte colony-stimulating factor increases muscle strength in neuromuscular disorders

Pediatr Neurol. 2014 Mar;50(3):e9. doi: 10.1016/j.pediatrneurol.2013.11.016. Epub 2013 Dec 4.

Affiliations

¹ Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland. Electronic address: kneur2@wp.pl.
² Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
³ Department of Pediatric Laboratory Diagnostics, Medical University of Białystok, Białystok, Poland.
⁴ Department of Neurology, Medical University of Białystok, Białystok, Poland.

PMID: 24530153
DOI: 10.1016/j.pediatrneurol.2013.11.016

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Filgrastim
Granulocyte Colony-Stimulating Factor / adverse effects
Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Kyphosis / complications
Male
Muscle Strength / drug effects*
Muscular Dystrophy, Facioscapulohumeral / complications
Muscular Dystrophy, Facioscapulohumeral / drug therapy*
Neuromuscular Agents / adverse effects
Neuromuscular Agents / therapeutic use*
Paraparesis, Spastic / complications
Recombinant Proteins / adverse effects
Recombinant Proteins / therapeutic use
Scoliosis / complications

Substances

Neuromuscular Agents
Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim